Details for: SANDOSTATIN
Company: NOVARTIS PHARMACEUTICALS CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02239323 | SANDOSTATIN LAR | OCTREOTIDE (OCTREOTIDE ACETATE) | 10 MG / VIAL | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | INTRAMUSCULAR |
| 02239324 | SANDOSTATIN LAR | OCTREOTIDE (OCTREOTIDE ACETATE) | 20 MG / VIAL | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | INTRAMUSCULAR |
| 02239325 | SANDOSTATIN LAR | OCTREOTIDE (OCTREOTIDE ACETATE) | 30 MG / VIAL | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | INTRAMUSCULAR |
| 00839191 | SANDOSTATIN | OCTREOTIDE (OCTREOTIDE ACETATE) | 50 MCG / ML | SOLUTION | INTRAVENOUS |
| 00839191 | SANDOSTATIN | OCTREOTIDE (OCTREOTIDE ACETATE) | 50 MCG / ML | SOLUTION | SUBCUTANEOUS |
| 00839205 | SANDOSTATIN | OCTREOTIDE (OCTREOTIDE ACETATE) | 100 MCG / ML | SOLUTION | SUBCUTANEOUS |
| 00839205 | SANDOSTATIN | OCTREOTIDE (OCTREOTIDE ACETATE) | 100 MCG / ML | SOLUTION | INTRAVENOUS |
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.